Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

BACKGROUND: Statins may be protective in severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection. The aim of the current study was to evaluate the effect of in-hospital statin use on 28-day mortality rates and intensive care unit (ICU) admission among patients with SARS-CoV-2, stratifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Memel, Zoe N, Lee, Jenny J, Foulkes, Andrea S, Chung, Raymond T, Thaweethai, Tanayott, Bloom, Patricia P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586726/
https://www.ncbi.nlm.nih.gov/pubmed/34665852
http://dx.doi.org/10.1093/infdis/jiab539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586726/
https://www.ncbi.nlm.nih.gov/pubmed/34665852
http://dx.doi.org/10.1093/infdis/jiab539

Ejemplares similares